![Göran Albert Ando](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Göran Albert Ando
Vorsitzender bei
EYEPOINT, INC.
Vermögen: 161 088 $ am 31.07.2026
Profil
Gründer des American College of Rheumatology, Gran Albert Torstensson Ando ist ein schwedischer Geschäftsmann, der an der Spitze von 14 verschiedenen Unternehmen stand und Non-Executive Chairman von EyePoint Pharmaceuticals, Inc. ist, Chairman von Tessa Therapeutics Pte Ltd, Chairman bei Nanexa AB, Chairman bei Nouscom AG und Chairman für SWMF Life Science Venture Fund LP. Er ist außerdem Senior Advisor bei Essex Woodlands Health Ventures UK Ltd. und im Vorstand von 7 weiteren Unternehmen. In seiner früheren Karriere war Dr. Ando Vorsitzender bei Novo Nordisk An und stellvertretender Vorsitzender bei Novo Nordisk Ltd. (eine Tochtergesellschaft von Novo Nordisk A), Aufsichtsratsvorsitzender der Trigen Holdings AG, Vorsitzender der Astra Research Centre AB, Non-Executive Chairman bei Inion Oy, Vorsitzender bei Pharmacia Biotech AB, Vorsitzender bei Novexel SA, Vorsitzender bei Symphogen A, Chief Executive Officer bei Celltech Group Plc, Executive VP-Worldwide Science & Technology bei Pharmacia & Upjohn, Inc, Vice President-Medical & Scientific Affairs bei Bristol-Myers Squibb Pharma Research Labs LLC, Executive VP, President-Research & Development bei Pharmacia Corp., Director-Research & Development bei Glaxo Group Ltd, Medical Director bei Pfizer AB, Member-Scientific Council bei H. Lundbeck A, Executive VP & Deputy Chief Executive Officer bei Pharmacia AB und Head-Clinical Research bei Pfizer International LLC. Er erhielt einen Doktortitel von der Universität Linkping und einen Bachelor-Abschluss von der Universität Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EYEPOINT, INC. 0.02% | 21.04.2026 | 13’150 ( 0.02% ) | 161 088 $ | 31.07.2026 |
Aktive Positionen von Göran Albert Ando
| Unternehmen | Position | Beginn |
|---|---|---|
| EYEPOINT, INC. | Vorsitzender | 10.09.2018 |
| NANEXA AB | Vorsitzender | 02.06.2020 |
Essex Woodlands Health Ventures UK Ltd.
 Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
RAND Health | Direktor/Vorstandsmitglied | - |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Direktor/Vorstandsmitglied | 21.04.2015 |
The International Centre for Missing & Exploited Children
 The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services Operates as a non-profit organization | Direktor/Vorstandsmitglied | - |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets late-stage oncology, oncology supportive care and critical care products | Direktor/Vorstandsmitglied | - |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Vorsitzender | 11.12.2020 |
Nouscom Srl
 Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Vorsitzender | - |
| ░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Göran Albert Ando
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Göran Albert Ando
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
45
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 45 |
|---|---|
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Inion Oy
 Inion Oy BiotechnologyHealth Technology Develops and manufactures biomaterial-based medical devices | Health Technology |
The International Centre for Missing & Exploited Children
The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services Operates as a non-profit organization | Health Services |
SWMF Life Science Venture Fund LP
 SWMF Life Science Venture Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Pharmacia Biotech AB
 Pharmacia Biotech AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Commercial Services |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDBI invests in companies located in Asia primarily in Singapore. The firm focuses on bio-based economy, green economy, next-generation hardware, mobility, health & wellness and digital economy sectors. It provides equity financing for later stage capital requirements. | Finance |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Researches and develops anti-infective drugs for the treatment of bacterial and fungal infections | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
Glaxo Group Ltd.
 Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company and manufactures pharmaceuticals | Health Technology |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology Develops new generation products for the treatment of autoimmune and inflammatory diseases | Health Technology |
RAND Health | |
Archimedes Pharma UK Ltd.
 Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers novel targeted small molecule drugs | Health Technology |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Essex Woodlands Health Ventures UK Ltd.
Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Albea Pharmaceuticals AG
 Albea Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Developes pharmaceutical products | Health Technology |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services Operates as an organization for physicians and health professionals | Commercial Services |
Pfizer International LLC
 Pfizer International LLC Aerospace & DefenseElectronic Technology Part of Pfizer Inc., Pfizer International LLC is an American company that is in relentless pursuit of medicines and vaccines that will benefit patients around the world. The company is based in NY. The company is committed to treating 225M people with breakthrough treatments by 2025. At Pfizer, their biotechnology is their foundation. With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are their focus. | Electronic Technology |
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets late-stage oncology, oncology supportive care and critical care products | Health Technology |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Pfizer AB | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Astra Research Centre AB | |
Nanexa AB
 Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
